306 results on '"Jannin, Vincent"'
Search Results
52. Formulation of Lipid Multi-Particulates: Evaluation of three technologies for targeted product profile using science and engineering approach
53. In vitro evaluation of leuprolide-containing solid lipid-based nanosuspensions: ability to encapsulate, release, protect and permeate in the gastrointestinal tract
54. In Vitro Studies Indicate Promising Properties Of Solid Lipid Nanosuspensions For Oral Peptide Delivery
55. Formulation of Lipid Multi-Particulates – Part 1: Evaluation of Melt-Spray Congealing and Direct Injection for targeted product profile using science and engineering approach
56. Investigation of Labrasol® ALF as an intestinal permeation enhancer: Ussing chambers and intestinal instillations
57. Improving adherence and efficacy of topical drug delivery, an industry perspective
58. Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems
59. Oral delivery of non-viral nucleic acid-based therapeutics - do we have the guts for this?
60. Benefits of lipid-based excipients in oral peptide formulations
61. Size characterization of micelles and microemulsions by Taylor dispersion analysis - COLL 789
62. Labrasol® is an efficacious non-damaging intestinal permeation enhancer in isolated rat intestinal mucosae
63. Lipid-based formulations – impact of lipolysis on colloid formation and drug solubilization
64. Advances in peptide delivery: HIP in SEDDS for solubilization, protection, and enhanced delivery of oral peptides - COLL 546
65. Bioavailable Curcumin - A Type 4 Lipid Based Drug Delivery System Using Gelucire® 48/16 As Solid Solubilizer
66. SEDDS-Self-emulsifying lipid droplets to enhance the solubility, stability, and absorption of poorly orally-bioavailable drugs
67. A Novel Approach To Prepare Solid Self-microemulsifying Drug Delivery System Without A Solid-phase Carrier Using 3D Printing
68. We've come a long, long way together: investigating the fascinating structures and functions of lipid excipients in drug delivery
69. Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems
70. In-vitro evaluation of solid lipid nanoparticles: Ability to encapsulate, release and ensure effective protection of peptides in the gastrointestinal tract
71. Oral delivery of non-viral nucleic acid-based therapeutics - do we have the guts for this?
72. Colloidal aspects of dispersion and digestion of self-dispersing lipid-based formulations for poorly water-soluble drugs
73. Lipids and polymers in pharmaceutical technology: Lifelong companions
74. Peptide release from SEDDS containing hydrophobic ion pair therapeutic peptides measured by Taylor dispersion analysis
75. Penetration and Permeation Enhancers for Oral Delivery of Peptides
76. Oral delivery of peptides
77. Lipid-based formulations; solubilizing and super-saturating systems with complex interplay with cell membranes
78. Solubilisation behaviour of poorly water-soluble drugs during digestion of solid SMEDDS
79. Complex Interplay Between Solubilization, Digestion, Supersaturation and Absorption of Poorly Soluble Drugs with Lipid-Based Formulations
80. Lipid-based nanosuspensions for oral delivery of peptides, a critical review
81. Solidification of liquid self-emulsifying lipid formulations by loading on solid mesoporous carriers
82. Solid State Structural Aspects of Solid Self-microemulsifying Drug Delivery Systems (sSMEDDS) during Digestion
83. Comparison of the protective effect of self-emulsifying peptide drug delivery systems towards intestinal proteases and glutathione
84. In-vitro investigation regarding the effects of Gelucire ® 44/14 and Labrasol® ALF on the secretory intestinal transport of P-gp substrates
85. Tabletting of solid particles obtained by adsorbing liquid or semi-solid lipid formulations onto inert carriers
86. Formulation of solid self-emulsifying lipid formulations by adsorption on solid carriers
87. Formulation of a self-emulsifying lipid formulation of Nifedipine
88. New Insights into the Stability of SR Lipid Matrix Tablets
89. Formulation of a self-emulsifying lipid formulation of curcumin
90. Establishment of a binary phase diagrams database for the development of self-emulsifying lipid-based formulations
91. Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations. 5. Lipolysis of Representative Formulations by Gastric Lipase
92. SELF formulation protocol: Part II - Excipient selection, diagram design and selection of prototype
93. In vitro lipolysis study of nanoparticulate Delivery systems: Solid Lipid Nanoparticles and Nanostructured Lipid Carriers
94. Influence of intestinal biorelevant fluids on a novel co-culture cell model able to mimic variable permeabilities of the human intestine
95. SELF formulation protocol: Part I - Solubility determination in liquid and solid excipients
96. SELF formulation protocol: Part III - Impact of lipolysis on prototype formulations
97. Characterization of a new self-emulsifying excipient to expand formulation options for poorly soluble drugs: Gelucire® 48/16
98. The LFCS Consortium: 4-Solubilisation of a weak base during in vitro digestion of 8 lipid-based formulations under 3 different conditions
99. The LFCS Consortium: 1 - Effect of saturation level of a neutral drug and a weakly acidic drug on the performance of lipid-based formulations during in vitro digestion
100. Development of a novel co-culture cell model able to mimic variable permeabilities of the human intestine and tolerate biorelevant media
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.